Literature DB >> 28765005

Global burden of diarrheal diseases among children in developing countries: Incidence, etiology, and insights from new molecular diagnostic techniques.

Karen L Kotloff1, James A Platts-Mills2, Dilruba Nasrin3, Anna Roose4, William C Blackwelder3, Myron M Levine5.   

Abstract

The Global Enteric Multicenter Study (GEMS) demonstrated that Shigella and enterotoxigenic Escherichia coli (ETEC) producing heat stable toxin (ST) (either alone or in combination with heat labile toxin) are among the most important pathogens associated with moderate-to-severe diarrhea (MSD) in children younger than 5years of age living in developing countries. To inform the design of vaccines and other interventions, we reviewed published data and new results from GEMS characterizing the burden of Shigella and ST-ETEC infections. Clinical parameters were assessed to examine the value of various case definitions as indicators of MSD associated with Shigella and ST-ETEC for use in clinical trials. We discussed advantages and disadvantages of culture-based and culture-independent molecular diagnostics for detecting clinically and epidemiologically relevant disease. Shigella serotyping data from GEMS were examined to identify desirable components of Shigella and ETEC vaccines likely to confer broad protection. These findings can inform the development and implementation of vaccines to prevent these important infections among infants and children in developing countries.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  Developing countries; Diarrhea; ETEC; Shigella; Vaccine

Mesh:

Substances:

Year:  2017        PMID: 28765005     DOI: 10.1016/j.vaccine.2017.07.036

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  41 in total

1.  Culture of Rectal Swab Specimens for Enteric Bacterial Pathogens Decreases Time to Test Result While Preserving Assay Sensitivity Compared to Bulk Fecal Specimens.

Authors:  Sophonie Jean; Melanie L Yarbrough; Neil W Anderson; C A Burnham
Journal:  J Clin Microbiol       Date:  2019-05-24       Impact factor: 5.948

Review 2.  Shigella flexneri: an emerging pathogen.

Authors:  Iqbal Nisa; Muhammad Qasim; Nusrat Yasin; Rafi Ullah; Anwar Ali
Journal:  Folia Microbiol (Praha)       Date:  2020-02-05       Impact factor: 2.099

3.  Uses of pathogen detection data to estimate vaccine direct effects in case-control studies.

Authors:  Joseph A Lewnard
Journal:  J R Soc Interface       Date:  2020-08-12       Impact factor: 4.118

4.  Human Experimental Challenge With Enterotoxigenic Escherichia coli Elicits Immune Responses to Canonical and Novel Antigens Relevant to Vaccine Development.

Authors:  Subhra Chakraborty; Arlo Randall; Tim J Vickers; Doug Molina; Clayton D Harro; Barbara DeNearing; Jessica Brubaker; David A Sack; A Louis Bourgeois; Philip L Felgner; Xiaowu Liang; Sachin Mani; Heather Wenzel; R Reid Townsend; Petra E Gilmore; Michael J Darsley; David A Rasko; James M Fleckenstein
Journal:  J Infect Dis       Date:  2018-09-22       Impact factor: 5.226

Review 5.  Controlled Human Infection Models To Accelerate Vaccine Development.

Authors:  Robert K M Choy; A Louis Bourgeois; Christian F Ockenhouse; Richard I Walker; Rebecca L Sheets; Jorge Flores
Journal:  Clin Microbiol Rev       Date:  2022-07-06       Impact factor: 50.129

6.  Burden, Antibiotic Resistance, and Clonality of Shigella spp. Implicated in Community-Acquired Acute Diarrhoea in Lilongwe, Malawi.

Authors:  Abel F N D Phiri; Akebe Luther King Abia; Daniel Gyamfi Amoako; Rajab Mkakosya; Arnfinn Sundsfjord; Sabiha Y Essack; Gunnar Skov Simonsen
Journal:  Trop Med Infect Dis       Date:  2021-04-28

7.  Conformational and Immunogenicity Studies of the Shigella flexneri Serogroup 6 O-Antigen: The Effect of O-Acetylation.

Authors:  Nicole Inge Richardson; Neil Ravenscroft; Vanessa Arato; Davide Oldrini; Francesca Micoli; Michelle M Kuttel
Journal:  Vaccines (Basel)       Date:  2021-04-27

8.  Risk Factors of Diarrhoea among Children Under Five Years in Southwest Nigeria.

Authors:  Harriet U Ugboko; Obinna C Nwinyi; Solomon U Oranusi; Fasina F Fagbeminiyi
Journal:  Int J Microbiol       Date:  2021-02-26

9.  Development of spirulina for the manufacture and oral delivery of protein therapeutics.

Authors:  Benjamin W Jester; Hui Zhao; Mesfin Gewe; Thomas Adame; Lisa Perruzza; David T Bolick; Jan Agosti; Nhi Khuong; Rolf Kuestner; Caitlin Gamble; Kendra Cruickshank; Jeremy Ferrara; Rachelle Lim; Troy Paddock; Colin Brady; Stacey Ertel; Miaohua Zhang; Alex Pollock; Jamie Lee; Jian Xiong; Michael Tasch; Tracy Saveria; David Doughty; Jacob Marshall; Damian Carrieri; Lauren Goetsch; Jason Dang; Nathaniel Sanjaya; David Fletcher; Anissa Martinez; Bryce Kadis; Kristjan Sigmar; Esha Afreen; Tammy Nguyen; Amanda Randolph; Alexandria Taber; Ashley Krzeszowski; Brittney Robinett; David B Volkin; Fabio Grassi; Richard Guerrant; Ryo Takeuchi; Brian Finrow; Craig Behnke; James Roberts
Journal:  Nat Biotechnol       Date:  2022-03-21       Impact factor: 68.164

10.  Microbiota-targeted maternal antibodies protect neonates from enteric infection.

Authors:  Wen Zheng; Wenjing Zhao; Meng Wu; Xinyang Song; Florence Caro; Ximei Sun; Francesca Gazzaniga; Giuseppe Stefanetti; Sungwhan Oh; John J Mekalanos; Dennis L Kasper
Journal:  Nature       Date:  2020-01-08       Impact factor: 69.504

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.